Successful fractionated undiluted doses of COVID-19 vaccine in five
cases of suspected allergic reactions to the first dose
- Federica Rivolta
, - Camilla Cappelletti,
- Andrea Sangalli,
- Alessandra Chiei Gallo,
- Valerio Pravettoni
Abstract
After a suspected allergic reactions to first dose of mRNA COVID-19
vaccine, given the PEG skin tests negativity and tolerance in vivo to
PEG containing drugs, five patients were vaccinated with the second dose
of Pfizer-Biontech undergoing a fractional protocol, with antihistamine
premedication, without presenting immediate or delayed reactions.11 Apr 2022Submitted to Clinical Case Reports 12 Apr 2022Submission Checks Completed
12 Apr 2022Assigned to Editor
15 May 2022Reviewer(s) Assigned
19 Jun 2022Review(s) Completed, Editorial Evaluation Pending
19 Jun 2022Editorial Decision: Revise Minor
29 Jun 20221st Revision Received
01 Jul 2022Submission Checks Completed
01 Jul 2022Assigned to Editor
01 Jul 2022Review(s) Completed, Editorial Evaluation Pending
23 Jul 2022Editorial Decision: Accept
